Variant report
Variant | rs2518047 |
---|---|
Chromosome Location | chr10:5136360-5136361 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | SP1 | chr10:5136292-5138992 | A549 | lung: | n/a | chr10:5136552-5136562 chr10:5136548-5136562 chr10:5136551-5136563 chr10:5136551-5136563 chr10:5136552-5136561 chr10:5136507-5136528 |
2 | POLR2A | chr10:5136360-5136935 | U87 | brain: | n/a | n/a |
3 | ARID3A | chr10:5136259-5137212 | HepG2 | liver: | n/a | n/a |
4 | NFYB | chr10:5136275-5136945 | Hela-S3 | cervix: | n/a | chr10:5136517-5136527 |
5 | EP300 | chr10:5134927-5137485 | A549 | lung: | n/a | chr10:5135763-5135777 chr10:5136729-5136738 chr10:5136822-5136831 |
6 | MAX | chr10:5136266-5137368 | A549 | lung: | n/a | n/a |
7 | NFIC | chr10:5136359-5137065 | HepG2 | liver: | n/a | n/a |
8 | REST | chr10:5135146-5139228 | A549 | lung: | n/a | n/a |
9 | MYBL2 | chr10:5136356-5137283 | HepG2 | liver: | n/a | n/a |
10 | BCL3 | chr10:5134993-5138735 | A549 | lung: | n/a | chr10:5137586-5137595 chr10:5136770-5136779 |
11 | NFYA | chr10:5136276-5136778 | Hela-S3 | cervix: | n/a | chr10:5136517-5136527 |
12 | GABPA | chr10:5136355-5136956 | A549 | lung: | n/a | n/a |
13 | FOSL2 | chr10:5135165-5139175 | A549 | lung: | n/a | chr10:5136821-5136831 chr10:5136823-5136834 chr10:5136821-5136830 chr10:5136821-5136831 chr10:5138903-5138915 chr10:5136822-5136831 chr10:5136820-5136832 chr10:5136822-5136829 |
14 | TAF1 | chr10:5136270-5137752 | A549 | lung: | n/a | n/a |
15 | POLR2A | chr10:5136353-5136968 | Hela-S3 | cervix: | n/a | n/a |
16 | ETS1 | chr10:5136320-5137501 | A549 | lung: | n/a | chr10:5137247-5137258 chr10:5136557-5136570 chr10:5136552-5136569 |
17 | SRF | chr10:5136315-5136656 | HepG2 | liver: | n/a | chr10:5136481-5136492 |
18 | EP300 | chr10:5134998-5137746 | A549 | lung: | n/a | chr10:5135763-5135777 chr10:5136729-5136738 chr10:5137675-5137689 chr10:5136822-5136831 |
19 | TAF1 | chr10:5136353-5136942 | A549 | lung: | n/a | n/a |
20 | TCF12 | chr10:5134878-5139332 | A549 | lung: | n/a | n/a |
21 | TBP | chr10:5136188-5137642 | Hela-S3 | cervix: | n/a | n/a |
22 | SP1 | chr10:5134963-5137699 | A549 | lung: | n/a | chr10:5136552-5136562 chr10:5136548-5136562 chr10:5136551-5136563 chr10:5136551-5136563 chr10:5136552-5136561 chr10:5136507-5136528 |
23 | FOXA2 | chr10:5136289-5136780 | A549 | lung: | n/a | n/a |
24 | SIX5 | chr10:5135322-5136740 | A549 | lung: | n/a | chr10:5135954-5135963 chr10:5135380-5135394 chr10:5135382-5135391 |
25 | GATA3 | chr10:5136358-5137581 | A549 | lung: | n/a | chr10:5136435-5136456 |
26 | CTCF | chr10:5136062-5138926 | A549 | lung: | n/a | chr10:5137004-5137025 chr10:5137015-5137024 chr10:5137009-5137027 |
No data |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000239142 | TF binding region |
AKR1C3 | TF binding region |
ENSG00000165568 | Chromatin interaction |
ENSG00000196139 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10752001 | 0.88[CEU][hapmap];0.85[CHB][hapmap];0.83[TSI][hapmap];0.83[EUR][1000 genomes] |
rs10752002 | 0.84[EUR][1000 genomes] |
rs10752005 | 0.80[CHB][hapmap];1.00[JPT][hapmap];1.00[AFR][1000 genomes];0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10795242 | 0.87[CEU][hapmap];0.85[CHB][hapmap];0.84[EUR][1000 genomes] |
rs10795245 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs10904411 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs10904417 | 0.95[ASN][1000 genomes] |
rs10904419 | 0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10904421 | 0.85[CHB][hapmap];1.00[JPT][hapmap] |
rs11252922 | 0.93[CEU][hapmap];0.85[CHB][hapmap];0.89[EUR][1000 genomes] |
rs12387 | 0.94[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.86[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.91[TSI][hapmap];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12529 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs12571915 | 0.90[ASN][1000 genomes] |
rs12775468 | 1.00[AFR][1000 genomes];0.84[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs12775701 | 1.00[CHB][hapmap];1.00[JPT][hapmap] |
rs17134471 | 1.00[CHB][hapmap];1.00[JPT][hapmap] |
rs17134523 | 0.85[CHB][hapmap] |
rs1761603 | 0.85[EUR][1000 genomes] |
rs1781929 | 0.88[EUR][1000 genomes] |
rs1781930 | 0.88[EUR][1000 genomes] |
rs1892404 | 0.86[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs1937840 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs1937841 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs1937845 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs1937847 | 0.94[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.96[GIH][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];0.87[TSI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1937848 | 0.94[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.96[GIH][hapmap];1.00[LWK][hapmap];0.84[MEX][hapmap];0.91[TSI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1937849 | 0.94[CEU][hapmap];1.00[CHB][hapmap];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1937882 | 0.87[ASN][1000 genomes] |
rs1937904 | 0.97[ASN][1000 genomes] |
rs1937906 | 0.97[ASN][1000 genomes] |
rs1937916 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes] |
rs2154308 | 0.87[ASN][1000 genomes] |
rs2154309 | 0.90[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2186175 | 0.87[ASN][1000 genomes] |
rs2211624 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2211630 | 0.86[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap] |
rs2226260 | 0.86[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs2298305 | 1.00[CHB][hapmap];0.95[CHD][hapmap];0.85[GIH][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];1.00[ASN][1000 genomes] |
rs2398103 | 1.00[CHB][hapmap];0.92[CHD][hapmap];1.00[JPT][hapmap] |
rs2398186 | 0.90[EUR][1000 genomes] |
rs2398195 | 0.86[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs2398196 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.92[ASN][1000 genomes] |
rs2518049 | 0.94[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.96[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];0.91[TSI][hapmap];1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2801882 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs2801883 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs34573009 | 0.82[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs3750573 | 1.00[CHB][hapmap];0.92[CHD][hapmap];1.00[JPT][hapmap] |
rs3812617 | 0.85[CHB][hapmap];0.83[TSI][hapmap] |
rs4242785 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs4330990 | 0.85[EUR][1000 genomes] |
rs4436454 | 0.97[ASN][1000 genomes] |
rs4478887 | 0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4559587 | 1.00[LWK][hapmap] |
rs4622159 | 1.00[AFR][1000 genomes];0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs4880707 | 0.81[ASN][1000 genomes] |
rs4880708 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs4880710 | 0.85[CHB][hapmap];1.00[JPT][hapmap];0.88[AMR][1000 genomes];0.90[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4881395 | 0.83[CHB][hapmap];0.89[GIH][hapmap];0.83[TSI][hapmap];0.89[EUR][1000 genomes] |
rs4881396 | 0.87[CEU][hapmap];0.85[CHB][hapmap];0.89[EUR][1000 genomes] |
rs4881397 | 0.93[CEU][hapmap];0.85[CHB][hapmap];0.89[EUR][1000 genomes] |
rs4881403 | 0.84[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4881404 | 0.87[CEU][hapmap];1.00[CHB][hapmap];0.95[CHD][hapmap];0.85[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];0.91[TSI][hapmap];0.84[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs61854684 | 0.85[EUR][1000 genomes] |
rs61854687 | 0.81[EUR][1000 genomes] |
rs61854697 | 0.81[EUR][1000 genomes] |
rs6601898 | 0.88[CEU][hapmap];0.85[CHB][hapmap];0.85[GIH][hapmap];0.83[TSI][hapmap];0.83[EUR][1000 genomes] |
rs6601899 | 0.88[CEU][hapmap];0.85[CHB][hapmap];0.92[GIH][hapmap];1.00[LWK][hapmap];0.83[TSI][hapmap];0.83[EUR][1000 genomes] |
rs7067921 | 1.00[CHB][hapmap];0.92[CHD][hapmap];0.81[GIH][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap] |
rs7071638 | 0.83[EUR][1000 genomes] |
rs7074004 | 0.85[CHB][hapmap] |
rs7087111 | 0.85[CHB][hapmap] |
rs7091485 | 0.90[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7893682 | 0.91[ASN][1000 genomes] |
rs7898263 | 0.94[CEU][hapmap];0.85[CHB][hapmap];0.92[GIH][hapmap];0.87[TSI][hapmap];0.89[EUR][1000 genomes] |
rs7901781 | 0.88[CEU][hapmap];0.85[CHB][hapmap];0.82[GIH][hapmap];0.83[TSI][hapmap];0.87[EUR][1000 genomes] |
rs7907985 | 0.96[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7914117 | 0.86[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7917079 | 0.86[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7920135 | 1.00[AFR][1000 genomes];0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs878766 | 1.00[CHB][hapmap];0.88[CHD][hapmap];1.00[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv894792 | chr10:4832920-5498724 | Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
2 | nsv948794 | chr10:4863093-5227382 | Enhancers Strong transcription Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 18 gene(s) | inside rSNPs | diseases |
3 | nsv1045155 | chr10:4872239-5211318 | Enhancers Weak transcription Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 18 gene(s) | inside rSNPs | diseases |
4 | nsv1040343 | chr10:4872814-5196815 | Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
5 | nsv540462 | chr10:4872814-5196815 | Enhancers Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Strong transcription Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
6 | nsv869470 | chr10:4878904-5203685 | Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 18 gene(s) | inside rSNPs | diseases |
7 | nsv466713 | chr10:4901798-5319679 | Active TSS Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
8 | nsv549881 | chr10:4901798-5319679 | Enhancers Weak transcription Genic enhancers Strong transcription Active TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
9 | nsv534685 | chr10:4914018-5853324 | Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 68 gene(s) | inside rSNPs | diseases |
10 | nsv1050246 | chr10:4927428-5211318 | Enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
11 | nsv549882 | chr10:4943518-5203864 | Weak transcription Flanking Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
12 | esv2763913 | chr10:4961021-5321407 | Enhancers Flanking Active TSS Strong transcription Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 22 gene(s) | inside rSNPs | diseases |
13 | nsv1039386 | chr10:5008383-5348491 | Weak transcription Strong transcription Enhancers Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
14 | nsv1036566 | chr10:5037926-5261426 | Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
15 | nsv549883 | chr10:5037926-5275762 | Active TSS Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
16 | nsv1047484 | chr10:5076258-5261482 | Enhancers Strong transcription Flanking Active TSS Genic enhancers Weak transcription ZNF genes & repeats Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
17 | nsv1036291 | chr10:5076258-5456234 | Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
18 | nsv1042487 | chr10:5090313-5196900 | Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
19 | nsv540463 | chr10:5090313-5196900 | Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
20 | nsv540464 | chr10:5108345-5196815 | Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
21 | nsv540465 | chr10:5108345-5261482 | ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
22 | nsv540466 | chr10:5114577-5196815 | Active TSS Flanking Active TSS Enhancers Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
23 | nsv540467 | chr10:5114577-5225365 | Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
24 | nsv540468 | chr10:5114577-5261482 | Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
25 | nsv540469 | chr10:5120774-5225365 | Weak transcription Enhancers Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
26 | nsv540470 | chr10:5120774-5261482 | Flanking Active TSS Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
27 | nsv540471 | chr10:5133561-5261482 | Strong transcription Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
28 | nsv540472 | chr10:5133561-5284334 | Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:5135200-5136400 | Enhancers | NHEK | skin |
2 | chr10:5135400-5136600 | Weak transcription | Stomach Mucosa | stomach |
3 | chr10:5135400-5138000 | Active TSS | A549 | lung |
4 | chr10:5135800-5136400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr10:5135800-5138400 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr10:5136000-5136400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
7 | chr10:5136000-5139400 | Active TSS | Duodenum Mucosa | Duodenum |
8 | chr10:5136200-5136400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr10:5136200-5136400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr10:5136200-5136400 | Enhancers | Primary T helper cells fromperipheralblood | blood |
11 | chr10:5136200-5136400 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr10:5136200-5136400 | Enhancers | Adipose Nuclei | Adipose |
13 | chr10:5136200-5136400 | Flanking Active TSS | Liver | Liver |
14 | chr10:5136200-5136400 | Enhancers | HUVEC | blood vessel |
15 | chr10:5136200-5136400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
16 | chr10:5136200-5136600 | Enhancers | Fetal Intestine Large | intestine |
17 | chr10:5136200-5136600 | Enhancers | Fetal Intestine Small | intestine |
18 | chr10:5136200-5136600 | Active TSS | HepG2 | liver |
19 | chr10:5136200-5137600 | Active TSS | HMEC | breast |
20 | chr10:5136200-5138000 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr10:5136200-5138400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
22 | chr10:5136200-5138800 | Active TSS | Rectal Mucosa Donor 29 | rectum |